Steve E Kalloger (Steve Kalloger)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Cross Sectional

Advanced Cancer

Risk Assessment

Mitochondrial Dna

Top Venues

Cancer research communications

Biomarker insights

Health expectations : an international journal of public participation in health care and health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Steve E Kalloger, Amanda Watson, Shawn Sajkowski, Lorna Warwick
Cancer related fatigue and the additive effect of treatment in the context of lymphoma: An analysis of the Lymphoma Coalition's 2022 Global Patient Survey. Cancer research communications (2024)
Steve E Kalloger, Amanda Watson, Shawn Sajkowski, Lorna Warwick
Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient Survey. Cancer research communications 4 (6) (2024)
Steve E Kalloger, Amanda Watson, Shawn Sajkowski, Lorna Warwick
Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient Survey. Cancer research communications 4 (6) (2024)
Paalini Sathiyaseelan, Suganthi Chittaranjan, Steve E Kalloger, Jennifer Chan, Nancy E Go, Mario A Jardon, Cally J Ho, Theodore Hui, Jing Xu, Christine Chow, Dongxia Gao, Fraser D Johnson, William W Lockwood, Gregg B Morin, Daniel J Renouf, David F Schaeffer, Sharon M Gorski
ATG4B and ATG4A loss result in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. Journal of cell science (2023)
Steve E Kalloger, Cheryl Ho, Craig Mitton, Dean A Regier
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping review. Journal of cancer survivorship : research and practice (2022)
Steve E Kalloger, Joanna M Karasinska, Cassia Warren, Daniel J Renouf, David F Schaeffer
Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour Tissue. Biomarker insights 16 (2021)
Steve E Kalloger, Joanna M Karasinska, Martin S Keung, Danielle L Thompson, Julie Ho, Christine Chow, Dongxia Gao, James T Topham, Cassia Warren, Hui-Li Wong, Michael Kuan-Ching Lee, Daniel J Renouf, David F Schaeffer
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma. International journal of cancer 148 (2) (2020)
Samantha Pollard, Steve E Kalloger, Deirdre Weymann, Sophie Sun, Jennifer Nuk, Kasmintan A Schrader, Deirdre Weymann
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication. Health expectations : an international journal of public participation in health care and health policy 23 (4) (2020)
Adam S Ziada, Meng Ying Lu, Jarek Ignas-Menzies, Elijah Paintsil, Min Li, Onyema Ogbuagu, Sara Saberi, Anthony Y Y Hsieh, Beheroze Sattha, P Richard Harrigan, Steve E Kalloger, Hélène C F Côté, null null
Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infection. Aging cell 18 (6) (2019)
Basile Tessier-Cloutier, Steve E Kalloger, Mohammad Al-Kandari, Katy Milne, Dongxia Gao, Brad H Nelson, Daniel J Renouf, Brandon S Sheffield, David F Schaeffer
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma. BMC cancer 17 (1) (2017)